01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Spontaneous Coronary Artery Dissection

Sebastian Rogowski MD, Micha T. Maeder MD, Daniel Weilenmann MD, Philipp K. Haager MD, Peter Ammann MD, Franziska Rohner MD, Lucas Joerg MD, Hans Rickli MD

Objective: We sought to assess the angiographic and long‐term clinical outcomes in a predominantly medically treated population with spontaneous coronary artery dissection (SCAD).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry

Toru Naganuma MD, Antonio Colombo MD, Maciej Lesiak MD, Davide Capodanno MD, PhD, Tommaso Gori MD, PhD, Holger Nef MD, Giuseppe Caramanno MD, Christoph Naber MD, Carlo Di Mario MD, Neil Ruparelia MD, Piera Capranzano MD, Jens Wiebe MD, Aleksander Araszkiewicz MD, Salvatore Geraci MD, Hiroyoshi Kawamoto MD, Stelios Pyxaras MD, Alessio Mattesini MD, Thomas Münzel MD, Corrado Tamburino MD, PhD, Azeem Latib MD

Objectives: The aim of this study was to evaluate midterm outcomes of bioresorbable vascular scaffolds (BVS) implanted in bifurcation lesions.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

Carlos Haiek MD, Carlos Fernández‐Pereira MD, PhD, FSCAI, Omar Santaera MD, Juan Mieres MD, Ignacio Rifourcat MD, Juan Lloberas MD, Miguel Larribau MD, Antonio Pocoví MD, Alfredo M. Rodriguez‐Granillo MD, Ricardo A. Sarmiento MD, David Antoniucci MD, FESC, Alfredo E. Rodriguez MD, PhD, FSCAI, FACC

Objective: To compare second generation drug eluting stents (2DES) with first generation (1DES) for the treatment of patients (pts) with multiple coronary vessel disease (MVD).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study

Philippe Généreux MD, Björn Redfors MD, PhD, Bernhard Witzenbichler MD, Akiko Maehara MD, Mayank Yadav MD, Giora Weisz MD, Dominic P. Francese MPH, Rupa Parvataneni MS, Sorin J. Brener MD, Roxana Mehran MD, Ajay J. Kirtane MD, SM, Gregg W. Stone MD

Objectives: We sought to identify angiographic predictors of 2‐year stent thrombosis (ST) in the ADAPT‐DES study.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Long‐term outcomes following mini‐crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New‐Tokyo (MITO) registry

Hiroyoshi Kawamoto MD, Kensuke Takagi MD, Alaide Chieffo MD, Neil Ruparelia DPHIL, MRCP, Yusuke Fujino MD, PhD, Hiroto Yabushita MD, Yusuke Watanabe MD, Azeem Latib MD, Mauro Carlino MD, Matteo Montorfano MD, Sunao Nakamura MD, PhD, Antonio Colombo MD

Objectives: This study aimed to investigate the long‐term outcomes following mini‐crush versus culotte stenting with drug‐eluting stents (DES) for the treatment of unprotected left main coronary artery (LMCA) disease.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Long‐term prognostic value of risk scores after drug‐eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR‐LEFT‐MAIN and ISAR‐LEFT‐MAIN 2 randomized clinical trials

Erion Xhepa MD, Tomohisa Tada MD, Sebastian Kufner MD, Gjin Ndrepepa MD, Robert A. Byrne MB BcH, PhD, Johanna Kreutzer MD, Tareq Ibrahim MD, Klaus Tiroch MD, Marco Valgimigli MD, PhD, Ralf Tölg MD, Salvatore Cassese MD, PhD, Massimiliano Fusaro MD, Heribert Schunkert MD, Karl L. Laugwitz MD, Julinda Mehilli MD, Adnan Kastrati MD

Objectives: To evaluate the long‐term prognostic value of risk scores in the setting of drug‐eluting stent (DES) implantation for uLMCA.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transcatheter aortic valve implantation with the self‐expandable venus A‐Valve and CoreValve devices: Preliminary Experiences in China

Yan‐Biao Liao MD, Zhen‐Gang Zhao MD, Xin Wei MD, Yuan‐Ning Xu MD, Zhi‐Liang Zuo MS, Yi‐jian Li MD, Ming‐Xia Zheng MS, Yuan Feng MD, Mao Chen MD, PhD

Background: Transcatheter aortic valve implantation (TAVI) has been demonstrated to be an effective alternative to surgical aortic valve replacement (SAVR) in patients with aortic stenosis who are deemed high risk or inoperable. Currently, TAVI procedures in China mostly make use of the domestic Venus A‐Valve and the CoreValve; however, there is no data on their comparative performance.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy

Bo Xu MBBS, Nicolas Bettinger MD, Changdong Guan MSC, Björn Redfors MD, PhD, Yuejin Yang MD, Bao Li MD, Yaling Han MD, PhD, Xi Su MD, Zuyi Yuan MD, Philippe Généreux MD

Objectives: We sought to study whether the level of completeness of revascularization as measured by the SYNTAX revascularization index (SRI) independently predicts adverse ischemic events after percutaneous coronary intervention (PCI) with second‐generation drug‐eluting stents (DES).

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Effect of coronary dominance on 2‐year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome

Chen He PhD, Yuan‐Liang Ma MD, Chuang‐Shi Wang PhD, Ying Song PhD, Xiao‐Fang Tang PhD, Xue‐Yan Zhao PhD, Run‐Lin Gao MD, Yue‐Jin Yang MD, Bo Xu MBBS and Jin‐Qing Yuan MD, PhD

Objectives: This retrospective, single‐center, observational analysis from prospectively collected database evaluated whether left dominance affected the long‐term outcomes of acute coronary syndrome patients undergoing percutaneous coronary intervention, and whether the effect was independent of SYNTAX score.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Safety and efficacy of 6‐month versus 12‐month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer‐coated sirolimus‐eluting coronary stents: Insight from the I‐LOVE‐IT 2 trial

Jing Qi MD, Yi Li MD, Jing Li MD, Quanmin Jing MD, Kai Xu MD, Chuanyu Gao MD, Likun Ma MD, Zhi Zhang MD, Bo Xu MD, Yaling Han MD, PhD

Objective: This study sought to compare the clinical outcomes of 6‐month versus 12‐month dual antiplatelet therapy (DAPT) in patients receiving multiple biodegradable polymer‐coated sirolimus‐eluting stents (BP‐SES) implants.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of six versus 12 months of dual antiplatelet therapy in patients with drug‐eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I‐LOVE‐IT 2 trial

Miaohan Qiu, Yi Li, Jing Li, Kai Xu, Quanmin Jing, Shaohong Dong, Zhe Jin, Pitian Zhao, Bo Xu, Yaling Han

Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug‐eluting stent (DES) implantation remains undetermined, especially for those at high risk of cardiac events postprocedure.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Long‐term clinical outcomes of successful revascularization with drug‐eluting stents for chronic total occlusions: A systematic review and meta‐analysis

Lei Gao, Yabin Wang, Yuqi Liu, Feng Cao, Yundai Chen

Objectives: To determine whether successful percutaneous coronary intervention (PCI) using drug‐eluting stents (DESs) have beneficial effects on long‐term outcomes in patients with chronic total occlusions (CTOs) compared with failed PCIs for CTOs.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation

Haibo Jia MD, PhD, Sining Hu MD, Huimin Liu MD, Yinchun Zhu MD, Chun‐yang Zhe MD, Lulu Li MD, Irina Mustafina MD, Jingbo Hou MD, PhD, Shaosong Zhang MD, PhD, Bo Yu MD, PhD

Objectives: To compare stent coverage and malapposition in patients with chronic total occlusion (CTO) lesions and non‐CTO lesions (including lipid‐rich plaque [LRP] and non‐lipid‐rich plaque [non‐LRP]) after drug‐eluting stent (DES) implantation by optical coherence tomography (OCT).

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome

Sining Hu MD, Chao Wang MD, Chunyang Zhe MD, Yinchun Zhu MD, Taishi Yonetsu MD, Haibo Jia MD, PhD Jingbo Hou MD, PhD Shaosong Zhang MD, PhD, Ik‐Kyung Jang MD, PhD, Bo Yu MD, PhD

Objectives: To compare vascular healing after drug‐eluting stent (DES) implantation between plaque rupture (PR) and plaque erosion (PE).

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Subclavian artery stenting for coronary‐subclavian steal syndrome

Wuqiang Che MS, Hui Dong MD, Xiongjing Jiang MD, Meng Peng MD, Yubao Zou MD, Lei Song MD, Huimin Zhang MD, Yuejin Yang MD, FACC, Runlin Gao MD, FACC

Objectives: To evaluate the safety and feasibility of subclavian artery stenting for coronary‐subclavian steal syndrome (CSSS).